Published on: 5 September 2022 Swissmedic grants Roche authorisation extension for prophylactic treatment in people with moderate or mild haemophilia A more
Published on: 2 September 2022 Roche inaugurates Building 2, one of the world's most sustainable high-rise office buildings more
Published on: 7 June 2022 Roche’s Vabysmo approved by Swissmedic as the first bispecific antibody for the eye to treat two leading causes of vision loss more
Subscribe to Roche Media Releases for Switzerland Get the latest news and updates to your inbox. more
